CRVO vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

CRVO

35.6
AI Score
VS
CRVO Wins

CLYM

32.7
AI Score

Investment Advisor Scores

CRVO

36score
Recommendation
SELL

CLYM

33score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric CRVO CLYM Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -99.6% 0.0% CLYM
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 35.6/100 32.7/100 CRVO
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation SELL EXTENDED CLYM

Relative Price Performance (Last 90 Days)

CRVO 1M: +3.5% · 3M: -12.8% CLYM 1M: +30.8% · 3M: +34.4%

Current Technical Phase

CRVO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.2%), weak momentum, RSI 44

RSI (14): 44.4 · Price: $2.65

CLYM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (13.2% over 20 days), RSI 57

RSI (14): 56.9 · Price: $16.08

Fundamentals Snapshot

Metric CRVO CLYM
Market Cap
Forward P/E -1.8 -15.3
Trailing P/E
Revenue (TTM)
Revenue Growth -1.0% 0.0%
Gross Margin -64.9%
Operating Margin -94.1% 0.0%
EPS -3.23 -0.82
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CRVO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.